The RECEPTOR Trial is Under Construction. Everything on this site is a draft, even the acknowledgements. Thanks for visiting this site. This trial is the primary research project of Allen Pannell. Please contact Allen at [email protected] for questions or comments. Click here for the key research paper on this topic.
The Receptor Trial
A Pragmatic Clinical Trial to Determine the Best Treatment Decision in Relapsed Metastatic Breast Cancer with Discordant Tumor Receptors
The RECEPTOR Trial is a clinical trial for metastatic breast cancer patients whose tumor receptors in their metastatic tumors are different from (discordant) their primary tumors.
<– Please visit the other pages on this site:
The Team: The advisors on this project
Objective: The purpose of this trial
Work Product: Key research output for the trial
Supporters: Those who donated time and money to support this effort